Ex-OpenAI Science Head Kevin Weil Launches Startup With $215 Million

Covered by 3 sourcesPublished 4 days ago

Kevin Weil, ex-head of AI science at OpenAI, has founded a new startup focused on accelerating drug development using artificial intelligence, backed by $215 million in funding.

Covered by 3 sources

Unite.AI
The Next Web
Bloomberg

#biotechnology #drug-development #kevin-weil #openai

Ex-OpenAI Science Head Kevin Weil Launches Startup With $215 Million

Covered by 3 sources

More in Healthcare

AI-Driven Inventory Optimization As An Operating Model Framework

Healthcare AI Agents Are Here—The Hugging Face Hack Shows Why They Need Guardrails

Machine learning dataset and benchmark for accurate T cell receptor–pHLA binding prediction